Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Seerapani Gopaluni"'
Autor:
Mark E. McClure, Seerapani Gopaluni, James Wason, Robert B. Henderson, Andre Van Maurik, Caroline C.O. Savage, Charles D. Pusey, Alan D. Salama, Paul A. Lyons, Jacinta Lee, Kim Mynard, David R. Jayne, Rachel B. Jones, on behalf the COMBIVAS investigators
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Sequential B cell-targeted immunotherapy with BAFF antagonism (belimumab) and B cell depletion (rituximab) may enhance B cell targeting in ANCA-associated vasculitis (AAV) through several mechanisms. Methods Study design: COMBIVAS
Externí odkaz:
https://doaj.org/article/de0d5603a4e24992b66dd2efe0d957ae
Autor:
Seerapani Gopaluni, Rona Smith, Donna Goymer, Hugh Cahill, Elizabeth Broadhurst, Elizabeth Wallin, Mark McClure, Afzal Chaudhry, David Jayne
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background Primary systemic vasculitis (PSV) is a heterogeneous group of autoimmune conditions. There is an unmet need for alternative therapies that lead to sustained remission in patients with refractory disease. Alemtuzumab, an anti-CD52
Externí odkaz:
https://doaj.org/article/2a7289713dcb49f9aa70eb54f28c80b3
Autor:
Josef Wagner, Ewan M. Harrison, Marcos Martinez Del Pero, Beth Blane, Gert Mayer, Johannes Leierer, Seerapani Gopaluni, Mark A. Holmes, Julian Parkhill, Sharon J. Peacock, David R. W. Jayne, Andreas Kronbichler
Publikováno v:
Microbiome, Vol 7, Iss 1, Pp 1-17 (2019)
Abstract Background Ear, nose and throat involvement in granulomatosis with polyangiitis (GPA) is frequently the initial disease manifestation. Previous investigations have observed a higher prevalence of Staphylococcus aureus in patients with GPA, a
Externí odkaz:
https://doaj.org/article/267567807e214569b56c28d0ff7572be
Autor:
Joanna Tieu, Rona M. Smith, Seerapani Gopaluni, Dinakantha S. Kumararatne, Mark McClure, Ania Manson, Sally Houghton, David R. W. Jayne
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveTo evaluate the characteristics of patients with autoimmune disease with hypogammaglobulinemia following rituximab (RTX) and describe their long-term outcomes, including those who commenced immunoglobulin replacement therapy.MethodsPatients
Externí odkaz:
https://doaj.org/article/bd3ce9c9a88440ebad989131ab748a89
Autor:
Allyson C. Egan, Andreas Kronbichler, Irmgard Neumann, Alessandra Bettiol, Nicholas Carlson, Maria C. Cid, Giacomo Emmi, Seerapani Gopaluni, Lorraine Harper, Thomas Hauser, Mark A. Little, Raashid A. Luqmani, Alfred Mahr, Mark McClure, Aladdin J. Mohammad, Karl Emil Nelveg-Kristensen, Sophie Ohlsson, Chen Au Peh, Matthew Rutherford, Beatriz Sanchez Alamo, Jennifer Scott, Mårten Segelmark, Rona M. Smith, Wladimir M. Szpirt, Gunnar Tomasson, Giorgio Trivioli, Augusto Vaglio, Michael Walsh, Maria Wester Trejo, Kerstin Westman, Ingeborg M. Bajema, David R.W. Jayne
Publikováno v:
Kidney International Reports. 7:1745-1757
The first European Vasculitis Society (EUVAS) meeting report was published in 2017. Herein, we report on developments in the past 5 years which were greatly influenced by the pandemic. The adaptability to engage virtually, at this critical time in so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc0d15f2b4c97731ccf5d9d2a5c4fb1
https://doi.org/10.1016/j.ekir.2022.05.018
https://doi.org/10.1016/j.ekir.2022.05.018
Autor:
Mark Edward McClure, Seerapani Gopaluni, James Wason, Robert B Henderson, Andre Van Maurik, Caroline Savage, Charles Pusey, Alan Salama, Paul A. Lyons, Jacinta Lee, Kim Mynard, David Jayne, Rachel Jones
Background. Sequential B cell targeted immunotherapy with BAFF antagonism (belimumab) and B cell depletion (rituximab) and may enhance B cell targeting in ANCA-associated vasculitis (AAV) through several mechanisms. Study Design. COMBIVAS is a random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::597f4ede1020f3f2267354c9ec601d64
https://doi.org/10.21203/rs.3.rs-2138639/v1
https://doi.org/10.21203/rs.3.rs-2138639/v1
Autor:
Jennifer Scott, Stephen P. McAdoo, Mark A. Little, David Jayne, Matthew A Rutherford, Rona M Smith, Maira Karabayas, D. Gray, Seerapani Gopaluni, Marilina Antonelou, Neeraj Dhaun, Neil Basu, Silke R. Brix, Colin C. Geddes, Alan D. Salama, Raashid Luqmani, Joe Barrett
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective COVID-19 is a novel infectious disease with a broad spectrum of clinical severity. Patients with systemic vasculitis have an increased risk of serious infections and may be at risk of severe outcomes following COVID-19. We undertook this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5195023e5972faf7eaf2892f3965cb1e
https://doi.org/10.1002/art.41728
https://doi.org/10.1002/art.41728
Publikováno v:
Rheumatology. 60:iii63-iii66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed470d471fafa0b83f67a35369a4b301
https://doi.org/10.1093/rheumatology/keab035
https://doi.org/10.1093/rheumatology/keab035
Autor:
Joanna Tieu, David Jayne, Seerapani Gopaluni, Rachel B Jones, Rona M Smith, Mark McClure, James Wason
Publikováno v:
J Clin Rheumatol
INTRODUCTION: The value of antineutrophil cytoplasmic antibody (ANCA) measurements among patients with an established diagnosis of ANCA-associated vasculitis (AAV) to assess disease activity or predict relapse remains controversial, but recent eviden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c013c96956d8755f9ba7a7b452c1fa5
https://doi.org/10.1097/rhu.0000000000001030
https://doi.org/10.1097/rhu.0000000000001030
Autor:
Seerapani Gopaluni, Mark McClure, Rachel B Jones, Tasneem Pope, Karl Emil Kristensen, Rona M Smith, Joanna Tieu, Jessica K. Barrett, David Jayne, Yajing Zhu
Publikováno v:
Rheumatology (Oxford, England)
ObjectivesFollowing a maintenance course of rituximab (RTX) for ANCA-associated vasculitis (AAV), relapses occur on cessation of therapy, and further dosing is considered. This study aimed to develop relapse and infection risk prediction models to he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb05008c7974ec698ce299eabbf879a4
https://www.repository.cam.ac.uk/handle/1810/313318
https://www.repository.cam.ac.uk/handle/1810/313318